$8.09
Price
$462M
Market Cap
—
P/E Ratio
-2.3
Forward P/E
$-3.75
EPS (TTM)
—
Dividend Yield
$305M
Cash
$25M
Total Debt
57M
Shares Out
$2.23
$12.34
52-Week Range
Institutional Ownership of 4D MOLECULAR THERAPEUTICS IN
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for 4D MOLECULAR THERAPEUTICS IN
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $15.51 | |
| 2024-Q1 | |||||
| SELL | -38.7% | 2.9M | $94M | $27.39 | |
| 2023-Q2 | |||||
| BUY | +21.6% | 4.8M | $87M | $18.06 | |
| 2020-Q4 | |||||
| BUY | NEW | 3.9M | $163M | $40.50 | |
Insider Trading for 4D MOLECULAR THERAPEUTICS IN
6 Months Insider Sentiment
Buy $0
Sell $21K
0
Buys
3
Sells
-21K
Net
0
Grants
Largest
$18K
Bizily
$11K
Theuer
$7K
Bizily
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 20, 2025 | Ashoo Gupta | VP, Finance and Controller | SELL | 310 | $8.68 | $3K |
| Dec 20, 2025 | Ashoo Gupta | VP, Finance and Controller | SELL | 79 | $8.68 | $686 |
| Dec 16, 2025 | Scott Bizily | Chief Legal Officer | EXERCISE | 1.6K | $4.14 | $7K |
| Dec 16, 2025 | Scott Bizily | Chief Legal Officer | SELL | 1.6K | $10.90 | $18K |
| Dec 12, 2025 | Charles Theuer | Director | EXERCISE | 9.3K | $1.14 | $11K |